RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients
Gastroenterology Review · 2026 · 21 (1) · 38-44
DOI: 10.5114/pg.2026.159896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Review, 2026. Verfasst von Konrad Lewandowski und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Internal Medicine, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Internal Medicine, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland.
- Department of Gastroenterology and Internal Medicine, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
- Department of Gastroenterology, Dietetics, and Internal Diseases, Poznan University of Medical Sciences, H. Święcicki University Hospital, Poznan, Poland.
- Department of Oncological Gastroenterology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
- Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland.
- Collegium Medicum, Jan Kochanowski University, Kielce, Poland.
Zitieren
APA
Lewandowski, K., Karłowicz, K., Sarbinowska, J., Gonciarz, M., Mahadea, D., Łykowska-Szuber, L., Eder, P., Chaber-Ciopińska, A., Zagórowicz, E., & Rydzewska, G. (2026). RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients. Gastroenterology Review, 21(1), 38-44. https://doi.org/10.5114/pg.2026.159896
Vancouver
Lewandowski K, Karłowicz K, Sarbinowska J, Gonciarz M, Mahadea D, Łykowska-Szuber L, et al. RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients. Gastroenterology Review. 2026;21(1):38-44. doi:10.5114/pg.2026.159896
BibTeX
@article{Lewandowski2026,
author = {Lewandowski, Konrad and Karłowicz, Katarzyna and Sarbinowska, Joanna and Gonciarz, Maciej and Mahadea, Dagmara and Łykowska-Szuber, Liliana and Eder, Piotr and Chaber-Ciopińska, Anna and Zagórowicz, Edyta and Rydzewska, Grażyna},
title = {RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients},
journal = {Gastroenterology Review},
year = {2026},
volume = {21},
number = {1},
pages = {38--44},
doi = {10.5114/pg.2026.159896}
}
EUVIMED